KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)DivestmentsDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Astrana Health (ASTH) Change in Receivables (2016 - 2025)

Historic Change in Receivables for Astrana Health (ASTH) over the last 16 years, with Q1 2025 value amounting to $10.4 million.

  • Astrana Health's Change in Receivables fell 6031.84% to $10.4 million in Q1 2025 from the same period last year, while for Mar 2025 it was $28.6 million, marking a year-over-year increase of 807.1%. This contributed to the annual value of $44.4 million for FY2024, which is 6602.95% up from last year.
  • According to the latest figures from Q1 2025, Astrana Health's Change in Receivables is $10.4 million, which was down 6031.84% from $6.5 million recorded in Q4 2024.
  • Over the past 5 years, Astrana Health's Change in Receivables peaked at $44.7 million during Q1 2022, and registered a low of -$20.1 million during Q4 2022.
  • Its 5-year average for Change in Receivables is $7.4 million, with a median of $6.5 million in 2024.
  • As far as peak fluctuations go, Astrana Health's Change in Receivables crashed by 182653.72% in 2021, and later soared by 187076.92% in 2022.
  • Astrana Health's Change in Receivables (Quarter) stood at -$5.3 million in 2021, then plummeted by 277.34% to -$20.1 million in 2022, then rose by 3.01% to -$19.5 million in 2023, then skyrocketed by 133.09% to $6.5 million in 2024, then skyrocketed by 60.47% to $10.4 million in 2025.
  • Its last three reported values are $10.4 million in Q1 2025, $6.5 million for Q4 2024, and -$85000.0 during Q3 2024.